Capricorn Energy 2023 Investor Update: NewMed Combination vs Palliser Plan

Capricorn Energy shareholder presentation addressing Palliser's alternative "Value Optimisation Plan" and defending the proposed NewMed Combination. The document corrects factual errors in Palliser's valuation analysis, demonstrating that the NewMed merger offers ~US$920m in upfront value with lower risk and faster delivery than Palliser's standalone plan.